Cancer cell and macrophage cross-talk in the tumor microenvironment

Current Opinion in Pharmacology

Volumn 35, Issue , 2017, Pages 12-19

  Dehne, Nathalie ^a   Mora, Javier ^a   Namgaladze, Dmitry ^a   Weigert, Andreas ^a   Brüne, Bernhard ^a,b  

^a GOETHE UNIVERSITY   (Germany)

^b FRAUNHOFER INSTITUTE FOR MOLECULAR BIOLOGY AND APPLIED ECOLOGY IME   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR NRF2; VASCULOTROPIN;

AUTOPHAGY; CANCER CELL; CELL DEATH; CELL INTERACTION; CELL METABOLISM; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; MACROPHAGE; NONHUMAN; NUCLEAR REPROGRAMMING; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; TUMOR HYPOXIA; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; HYPOXIA; METABOLISM; NEOPLASM;

ANIMALS; CELL DEATH; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MACROPHAGES; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 85019383098     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2017.04.007     Document Type: Review

References (53)

1. Michiels, C., Tellier, C., Feron, O., Cycling hypoxia: a key feature of the tumor microenvironment. Biochim. Biophys. Acta 1866 (2016), 76–86.
2. Brune, B., Dehne, N., Sensors, transmitters and targets in mitochondrial oxygen shortage—a HIF relay story. Antioxid. Redox Signal. 20 (2014), 339–352.
3. Henze, A.T., Acker, T., Feedback regulators of hypoxia-inducible factors and their role in cancer biology. Cell Cycle 9 (2010), 2749–2763.
4. Ohta, A., A metabolic immune checkpoint: adenosine in tumor microenvironment. Front. Immunol., 7, 2016, 109.
5. Zhong, Z., Sanchez-Lopez, E., Karin, M., Autophagy, inflammation, and immunity: a troika governing cancer and its treatment. Cell 166 (2016), 288–298.
6. Tameire, F., Verginadis, I.I., Koumenis, C., Cell intrinsic and extrinsic activators of the un folded protein response in cancer: mechanisms and targets for therapy. Semin. Cancer Biol. 33 (2015), 3–15.
7. Brune, B., Dehne, N., Grossmann, N., Jung, M., Namgaladze, D., Schmid, T., von Knethen, A., Weigert, A., Redox control of inflammation in macrophages. Antioxid. Redox Signal. 19 (2013), 595–637.
8. Ginhoux, F., Guilliams, M., Tissue-resident macrophage ontogeny and homeostasis. Immunity 44 (2016), 439–449.
9. Ugel, S., De Sanctis, F., Mandruzzato, S., Bronte, V., Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J. Clin. Investig. 125 (2015), 3365–3376.
10. Franklin, R.A., Liao, W., Sarkar, A., Kim, M.V., Bivona, M.R., Liu, K., Pamer, E.G., Li, M.O., The cellular and molecular origin of tumor-associated macrophages. Science 344 (2014), 921–925.
11. Murray, P.J., Allen, J.E., Biswas, S.K., Fisher, E.A., Gilroy, D.W., Goerdt, S., Gordon, S., Hamilton, J.A., Ivashkiv, L.B., Lawrence, T., et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41 (2014), 14–20.
12. 12•• Laoui, D., Van Overmeire, E., Di Conza, G., Aldeni, C., Keirsse, J., Morias, Y., Movahedi, K., Houbracken, I., Schouppe, E., Elkrim, Y., et al. Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population. Cancer Res. 74 (2014), 24–30 To assess the in vivo role of hypoxia on TAM features, cancer cells were inoculated in prolyl hydroxylase domain 2 (PHD2)-haplodeficient mice, resulting in better-oxygenated tumors. Reduced tumor hypoxia did not alter the relative abundance of TAM subsets nor their M2 marker expression, but specifically lowered hypoxia-sensitive gene expression and angiogenic activity in distinct TAM subsets. These results show that hypoxia is not a major driver of TAM subset differentiation, but rather fine-tunes the M2-phenotype.
13. Takeda, N., O'Dea, E.L., Doedens, A., Kim, J.W., Weidemann, A., Stockmann, C., Asagiri, M., Simon, M.C., Hoffmann, A., Johnson, R.S., Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev. 24 (2010), 491–501.
14. Henze, A.T., Mazzone, M., The impact of hypoxia on tumor-associated macrophages. J. Clin. Investig. 126 (2016), 3672–3679.
15. Dehne, N., Fuhrmann, D., Brune, B., Hypoxia-inducible factor (HIF) in hormone signaling during health and disease. Cardiovasc. Hematol. Agents Med. Chem. 11 (2013), 125–135.
16. Gonzalez, D.M., Medici, D., Signaling mechanisms of the epithelial–mesenchymal transition. Sci. Signal., 7, 2014, re8.
17. Huber, R., Meier, B., Otsuka, A., Fenini, G., Satoh, T., Gehrke, S., Widmer, D., Levesque, M.P., Mangana, J., Kerl, K., et al. Tumour hypoxia promotes melanoma growth and metastasis via high mobility group box-1 and M2-like macrophages. Sci. Rep., 6, 2016, 29914.
18. 18• Brand, A., Singer, K., Koehl, G.E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. LDHA-associated lactic acid production blunts tumor immunosurveillance by T and NK cells. Cell Metab. 24 (2016), 657–671 The authors link an altered tumor glucose metabolism to immune escape and show that lactate in cancer cells impairs cytokine production, in particular IFN-γ, in TAMs and NK cells, thereby inhibiting tumor immunosurveillance and promoting tumor growth. The work connects intermediary metabolism and immune responses to tumor progression.
19. Lim, S.O., Li, C.W., Xia, W., Lee, H.H., Chang, S.S., Shen, J., Hsu, J.L., Raftery, D., Djukovic, D., Gu, H., et al. EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape. Cancer Res. 76 (2016), 1284–1296.
20. Kellum, J.A., Song, M., Li, J., Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004), R686–692.
21. Perez-Escuredo, J., Dadhich, R.K., Dhup, S., Cacace, A., Van Hee, V.F., De Saedeleer, C.J., Sboarina, M., Rodriguez, F., Fontenille, M.J., Brisson, L., et al. Lactate promotes glutamine uptake and metabolism in oxidative cancer cells. Cell Cycle 15 (2016), 72–83.
22. Colegio, O.R., Chu, N.Q., Szabo, A.L., Chu, T., Rhebergen, A.M., Jairam, V., Cyrus, N., Brokowski, C.E., Eisenbarth, S.C., Phillips, G.M., et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513 (2014), 559–563.
23. Takeda, Y., Costa, S., Delamarre, E., Roncal, C., Leite de Oliveira, R., Squadrito, M.L., Finisguerra, V., Deschoemaeker, S., Bruyere, F., Wenes, M., et al. Macrophage skewing by Phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature 479 (2011), 122–126.
24. O'Neill, L.A.J., Pearce, E.J., Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213 (2016), 15–23.
25. Cramer, T., Yamanishi, Y., Clausen, B.E., Förster, I., Pawlinski, R., Mackman, N., Haase, V.H., Jaenisch, R., Corr, M., Nizet, V., et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112 (2003), 645–657.
26. Tausendschon, M., Rehli, M., Dehne, N., Schmidl, C., Doring, C., Hansmann, M.L., Brune, B., Genome-wide identification of hypoxia-inducible factor-1 and -2 binding sites in hypoxic human macrophages alternatively activated by IL-10. Biochim. Biophys. Acta 2015 (1849), 10–22.
27. 27• Liu, L., Lu, Y., Martinez, J., Bi, Y., Lian, G., Wang, T., Milasta, S., Wang, J., Yang, M., Liu, G., et al. Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1α-dependent. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 1564–1569 This paper shows that metabolic alterations in proliferating versus pro-inflammatory macrophage responses are distinctly dependent on the Myc and HIF-1α transcription factors.
28. Tannahill, G.M., Curtis, A.M., Adamik, J., Palsson-McDermott, E.M., McGettrick, A.F., Goel, G., Frezza, C., Bernard, N.J., Kelly, B., Foley, N.H., et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496 (2013), 238–242.
29. Cordes, T., Wallace, M., Michelucci, A., Divakaruni, A.S., Sapcariu, S.C., Sousa, C., Koseki, H., Cabrales, P., Murphy, A.N., Hiller, K., et al. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J. Biol. Chem. 291 (2016), 14274–14284.
30. Lampropoulou, V., Sergushichev, A., Bambouskova, M., Nair, S., Vincent, E.E., Loginicheva, E., Cervantes-Barragan, L., Ma, X., Huang, S.C., Griss, T., et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24 (2016), 158–166.
31. 31• Mills, E.L., Kelly, B., Logan, A., Costa, A.S.H., Varma, M., Bryant, C.E., Tourlomousis, P., Däbritz, J.H.M., Gottlieb, E., Latorre, I., et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167 (2016), 457–470 e413 The authors discover that the formation of mitochondrial reactive oxygen species demands increased succinate oxidation by succinate dehydrogenase complex, being essential for macrophage inflammatory responses to lipopolysaccharide.
32. Van den Bossche, J., Baardman, J., Otto, N.A., van der Velden, S., Neele, A.E., van den Berg, S.M., Luque-Martin, R., Chen, H.J., Boshuizen, M.C., Ahmed, M., et al. Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. 17 (2016), 684–696.
33. Penny, H.L., Sieow, J.L., Adriani, G., Yeap, W.H., See Chi Ee, P., San Luis, B., Lee, B., Lee, T., Mak, S.Y., Ho, Y.S., et al. Warburg metabolism in tumor-conditioned macrophages promotes metastasis in human pancreatic ductal adenocarcinoma. Oncoimmunology, 5, 2016, e1191731.
34. Gregory, C.D., Pound, J.D., Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues. J. Pathol. 223 (2011), 177–194.
35. Schreiber, R.D., Old, L.J., Smyth, M.J., Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331 (2011), 1565–1570.
36. Marino, G., Niso-Santano, M., Baehrecke, E.H., Kroemer, G., Self-consumption: the interplay of autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 15 (2014), 81–94.
37. Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouyssegur, J., Mazure, N.M., Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol. Cell. Biol. 29 (2009), 2570–2581.
38. Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M.G., Rimoldi, M., Biswas, S.K., Allavena, P., Mantovani, A., Macrophage polarization in tumour progression. Semin. Cancer Biol. 18 (2008), 349–355.
39. Weigert, A., Brune, B., Nitric oxide, apoptosis and macrophage polarization during tumor progression. Nitric Oxide 19 (2008), 95–102.
40. 40• Fadok, V.A., Voelker, D.R., Campbell, P.A., Cohen, J.J., Bratton, D.L., Henson, P.M., Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148 (1992), 2207–2216 This study demonstrates phosphatidylserine redistribution to the outer leaflet of the plasma membrane of apoptotic cells, where it is recognized by macrophages to initiate clearance, laying the groundwork for investigations on the consequences of apoptotic cell recognition by macrophages.
41. Weigert, A., Mora, J., Sekar, D., Syed, S., Brune, B., Killing is not enough: how apoptosis hijacks tumor-associated macrophages to promote cancer progression. Adv. Exp. Med. Biol. 930 (2016), 205–239.
42. Weigert, A., Johann, A.M., von Knethen, A., Schmidt, H., Geisslinger, G., Brune, B., Apoptotic cells promote macrophage survival by releasing the antiapoptotic mediator sphingosine-1-phosphate. Blood 108 (2006), 1635–1642.
43. Weigert, A., Schiffmann, S., Sekar, D., Ley, S., Menrad, H., Werno, C., Grosch, S., Geisslinger, G., Brune, B., Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. Int. J. Cancer 125 (2009), 2114–2121.
44. Cuvillier, O., Ader, I., Bouquerel, P., Brizuela, L., Gstalder, C., Malavaud, B., Hypoxia, therapeutic resistance, and sphingosine 1-phosphate. Adv. Cancer Res. 117 (2013), 117–141.
45. Brecht, K., Weigert, A., Hu, J., Popp, R., Fisslthaler, B., Korff, T., Fleming, I., Geisslinger, G., Brune, B., Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. FASEB J. 25 (2011), 2408–2417.
46. Olesch, C., Sha, W., Angioni, C., Sha, L.K., Acaf, E., Patrignani, P., Jakobsson, P.J., Radeke, H.H., Grosch, S., Geisslinger, G., et al. MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer. Oncotarget 6 (2015), 10284–10296.
47. 47• Fucikova, J., Becht, E., Iribarren, K., Goc, J., Remark, R., Damotte, D., Alifano, M., Devi, P., Biton, J., Germain, C., et al. Calreticulin expression in human non-small cell lung cancers correlates with increased accumulation of antitumor immune cells and favorable prognosis. Cancer Res. 76 (2016), 1746–1756 Expression of CRT, a marker of immunogenic cell death, translates into anti-tumor immunity in cancer patients, resulting in a good survival prognosis. This shows that the mode of cell death in tumors is connected to patient survival.
48. Michaud, M., Sukkurwala, A.Q., Di Sano, F., Zitvogel, L., Kepp, O., Kroemer, G., Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress. Oncoimmunology, 3, 2014, e28276.
49. Kuraishy, A., Karin, M., Grivennikov, S.I., Tumor promotion via injury- and death-induced inflammation. Immunity 35 (2011), 467–477.
50. Yang, H., Lundback, P., Ottosson, L., Erlandsson-Harris, H., Venereau, E., Bianchi, M.E., Al-Abed, Y., Andersson, U., Tracey, K.J., Antoine, D.J., Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol. Med. 18 (2012), 250–259.
51. Liu, A., Fang, H., Dirsch, O., Jin, H., Dahmen, U., Oxidation of HMGB1 causes attenuation of its pro-inflammatory activity and occurs during liver ischemia and reperfusion. PLoS One, 7, 2012, e35379.
52. Mora, J., Weigert, A., IL-1 family cytokines in cancer immunity—a matter of life and death. Biol. Chem. 397 (2016), 1125–1134.
53. Mora, J., Schlemmer, A., Wittig, I., Richter, F., Putyrski, M., Frank, A.C., Han, Y., Jung, M., Ernst, A., Weigert, A., et al. Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses. J. Mol. Cell Biol. 8 (2016), 426–438.